High-Sensitivity C-Reactive Protein and Cancer

High-Sensitivity C-Reactive Protein and Cancer

BACKGROUND High-sensitivity C-reactive protein (hs-CRP) is a commonly used inflammatory marker. The association between hs-CRP and cancer is less consistent than that between hs-CRP and cardiovascular diseases. This study explored the association between hs-CRP and cancer, using a large database of Korean health examination records. METHODS A total of 80,781 Koreans who visited the health pro...

High-sensitivity C-reactive protein levels and cancer mortality.

BACKGROUND High-sensitivity C-reactive protein (hs-CRP) is an important inflammatory marker, and inflammation is known to be involved in the initiation and progression of cancer. We investigated the association between serum hs-CRP levels and all-cause mortality, cancer mortality, and site-specific cancer mortality in apparently cancer-free Koreans. METHODS A total of 33,567 participants who ...

High-sensitivity C-reactive protein methods examined.

Steatosis DeLIVERs high-sensitivity C-reactive protein.

Nonalcoholic fatty liver disease is characterized by excess accumulation of lipids within parenchymal cells of the liver (ie, hepatocellular steatosis) in the absence of excessive ethanol consumption. Fatty liver disease is widely considered to be the hepatic manifestation of metabolic syndrome and is estimated to occur in more than 25% of the Western population.1 Nonalcoholic fatty liver disea...

Problems with high-sensitivity C-reactive protein.

To the Editor: Last year, Ockene et al. (1) published a report in this journal that made the claim that high-sensitivity C-reactive protein (hs-CRP) has a degree of measurement stability that is similar to that of total cholesterol and that this provides further evidence of the potential clinical utility of hs-CRP screening as a novel tool for vascular risk prediction. The key evidence that Ock...